skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Informa pharma logo

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

PharmaLogo
Search Icon Pharma Report StoreRecommendationsProduct loginProductLogin
Global Search Configuration

About Michael

UK

+7 year(s) experience

Michael Haydock | Pharma Intelligence
Director Michael Haydock oversees content production for cardiovascular and metabolic diseases as well as infectious disease and vaccine indications. In his role, Michael provides analysis and strategic recommendations on various disease markets through comparative assessment of marketed and pipeline products and patient-based forecasting.
His specialities include hepatitis B, hepatitis C, HIV, influenza, dengue, pneumococcal vaccines and meningococcal vaccines. In addition to producing analyses on various antiviral and vaccine indications, Michael has designed several primary research surveys, and is currently focused on refining data inputs and forecasting methodology. His greatest achievement is the development of an interactive, patient-based 10-year forecast for the early-phase RSV vaccines landscape – a particularly challenging task given the lack of currently approved vaccines.

He joined Informa as an analyst in 2012, having achieved a first-class degree in Natural Sciences (Immunology and Virology) from the University of Cambridge.

Specialties

  • Infectious Diseases
  • Cardiovascular
  • Metabolic
  • Vaccines

Michael Writes For

Analyst Articles

Articles by Michael